opinion articles

Send us a link

Subscribe to our newsletter

Dear Grant Agencies: Tell Me Where I Went Wrong

Dear Grant Agencies: Tell Me Where I Went Wrong

I don't expect to get every grant I apply for, but the least agencies could do is give me a little feedback, says Juan Manuel Parrilla Gutierrez.

Science Needs a Radical Overhaul

Science Needs a Radical Overhaul

Illusions of discovery are holding science back. But even if we wanted to do the right thing and evaluate scientific papers based on their quality, regardless of how flashy and exciting the claims of discovery may be, it’s not clear how we’d do that.

When More is More: Broad Calls for Multilingualism and Evaluation Reform

When More is More: Broad Calls for Multilingualism and Evaluation Reform

In recent years, numerous initiatives have highlighted linguistic biases embedded in current evaluation processes and have called for change. The DORA-hosted community discussion on multilingualism in scholarly evaluation was inspired by actions others have taken to address these issues.

The Publisher's Association's Impact Assessment on OA is Pretty Much As You'd Expect

The Publisher's Association's Impact Assessment on OA is Pretty Much As You'd Expect

The UK Publisher's Association has commissioned a report that seems to be their latest attempt at painting open access to research as economically damaging to the publishing sector.

Peer Reviewers - Time for Mass Rebellion?

Peer Reviewers - Time for Mass Rebellion?

Richard Smith spent some time reviewing two scientific papers, and the experience has made him wonder if it is time for peer reviewers to rise up in rebellion.

Publishing Philosophy Open Access Without a Particle Collider

Publishing Philosophy Open Access Without a Particle Collider

Open Access often appears to be a monolithic concept, covering all fields of research and publication. However, in practice its application is to a large extent determined by the needs and resource…

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

Significantly less government funding was put towards researching treatments than vaccines. And national efforts to coordinate and recruit sick patients into trials were insufficient. The next few months will still bring many sick people - and doctors have woefully few drugs with which to treat them.

Don't Believe the Hype: Repositories Are Critical for Ensuring Equity, Inclusion and Sustainability in the Transition to Open Access

Don't Believe the Hype: Repositories Are Critical for Ensuring Equity, Inclusion and Sustainability in the Transition to Open Access

The rhetoric of some scholarly publishers lately has shown a troublesome trend with respect to Open Access repositories (often referred to as Green OA).

Vaccine Experts Defend UK Decision to Delay Second Pfizer Covid Jab

Vaccine Experts Defend UK Decision to Delay Second Pfizer Covid Jab

Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned that the strategy was proving “ever-more difficult to justify” (see "Related" link).

Two Masks Are the New Masks

Two Masks Are the New Masks

Double-masking is a sensible and easy way to lower your risk when you have to spend more time around others - in a taxi, on a train or plane, or at an inauguration.